Modified Paclitaxel-loaded Nanoparticles for Inhibition of Hyperplasia in a Rabbit Arterial Balloon Injury Model
- 228 Downloads
This study tested the possibility of localized intravascular infusion of positive charged paclitaxel-loaded nanoparticles (NPs) to better prevent neointimal formation in a rabbit carotid artery injury model.
Materials and Methods
NPs were prepared by oil–water emulsion/solvent evaporation technique using biodegradable poly (lactide-co-glycolide) (PLGA). A cationic surfactant, didodecyldimethylammonium bromide (DMAB), was absorbed on the NP surface by electrostatic attraction between positive and negative charges. NPs were characterized in such aspects as size, surface morphology, surface charges as well as in vitro drug release profile. Balloon injured rabbit carotid arteries were treated with single infusion of paclitaxel-loaded NP suspension and observed for 28 days. The inhibitory effects of NPs on neointima formation were evaluated as end-point.
NPs showed spherical shape with a diameter ranging from 200 to 500 nm. Negatively charged PLGA NPs shifted to positive after the DMAB modification. The in vitro drug release profile showed a biphasic release pattern. Morphometric analyses on the retrieved artery samples revealed that the inhibitory effect of intima proliferation was dose-dependent. At a concentration of 30 mg ml−1, NP infusion completely inhibited intima proliferation in a rabbit vascular injury model.
Paclitaxel-loaded NPs with DMAB modification were proven an effective means of inhibiting proliferative response to vascular injury in a rabbit model.
Key wordsDMAB nanoparticle paclitaxel restenosis surface modification
common carotid artery
hematoxylin & eosin
high performance liquid chromatography
scanning electron microscopy
transmission electronic microscopy
vascular smooth muscle cell
- 2.U. Westedt, L. Barbu-Tudoran, A. K. Schaper, M. Kalinowsk, H. Alfke, and T. Kissel. Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy. AAPS PharmSci in vitro(4):1–6 (2004).Google Scholar
- 9.E. Grube, S. Silber, K. E. Hauptmann, R. Mueller, L. Buellesfeld, U. Gerckens, and M. E. Russell. TAXUS I: six- and 12-month results from a randomized, double-blind trial on a slow-release paclitaxeleluting stent for de novo coronary lesions. Circulation 107:38–42 (2003).PubMedCrossRefGoogle Scholar
- 11.J. W. Moses, M. B. Leon, J. J. Popma, P. J. Fitzgerald, D. R. Holmes, C. O’Shaughnessy, R. P. Caputo, D. J. Kereiakes, D. O. Williams, P. S. Teirstein, J. L. Jaeger, and R. E. Kuntz. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med. 349:1315–1323 (2003).PubMedCrossRefGoogle Scholar
- 12.S. Banai, M. Chorny, S. D. Gertz, I. Fishbein, J. Gao, L. Perez, G. Lazarovichi, A. Gazit, A. Levitzki, and G. Golomb. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials 26:4898–4901 (2005).CrossRefGoogle Scholar
- 17.F. Valero, M. Hamon, C. Fournier, T. Meurice, B. Flautre, E. Van Belle, J. M. Lablanche, B. Gosselin, C. Bauters, and M. Bertrand. Intramural injection of biodegradable microspheres as a local drug-delivery system to inhibit neointimal thickening in a rabbit model of balloon angioplasty. J. Cardiovasc. Pharmacol. 31(4):513–519 (1998).PubMedCrossRefGoogle Scholar
- 18.R. L. Wilensky, K. L. March, I. Gradus-Pizlo, D. Schauwecker, M. B. Michaels, J. Robinson, K. Carlson, and D. R. Hathaway. Regional and arterial localization of radioactive microparticles after local delivery by unsupported or supported porous balloon catheters. Am. Heart J. 129(5):852–859 (1995).PubMedCrossRefGoogle Scholar
- 22.W. R. Humphrey, L. A. Erickson, C. A. Simmons, J. L. Northrup, D. G. Wishka, J. Morris, V. Labhasetwar, C. Song, R. J. Levy, and R. J. Shebuski. The effect of intramural delivery of polymeric nanoparticles loaded with the anti-proliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured porcine coronary. Adv. Drug Deliv. Rev. 24:87–108 (1997).CrossRefGoogle Scholar
- 27.T. K. Nasser, R. L. Wilensky, K. Mehdi, and K. L. March. Microparticle deposition in periarterial microvasculature and intramural dissections after porous balloon delivery into atherosclerotic vessels: quantitation and localization by confocal scanning laser microscopy. Am. Heart J. 131(5):892–898 (1996).PubMedCrossRefGoogle Scholar
- 28.J. J. Rome, V. Shayani, M. Y. Flugelman, K. D. Newman, A. Farb, R. Virmani, and D. A. Dichek. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall: modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler. Thromb. 14:148–161 (1994).PubMedGoogle Scholar
- 30.I. Gradus-Pizlo, R. L. Wilensky, K. L. March, N. Fineberg, M. Michaels, G. E. Sandusky, and D. R. Hathaway. Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery. J. Am. Coll. Cardiol. 26(6):1549–1557 (1995).PubMedCrossRefGoogle Scholar
- 41.J. J. Wright and L. Illum. Active targeting of microcapsules and microspheres to specific regions. In M. Donbrow (ed.), Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC Press, Boca Raton, FL, 1992, pp. 282–293.Google Scholar